XML 17 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Beginning Balance at Dec. 31, 2019 $ 4,380,545 $ 2,443 $ 90,108,492 $ (85,730,390)
Beginning Balance, Shares at Dec. 31, 2019   24,431,914    
Stock-based compensation expense 310,162   310,162  
Issuance of common stock from employee stock purchase plan 21,250 $ 3 21,247  
Issuance of common stock from employee stock purchase plan, shares   25,000    
Net loss (1,790,309)     (1,790,309)
Ending Balance at Mar. 31, 2020 2,921,648 $ 2,446 90,439,901 (87,520,699)
Ending Balance, Shares at Mar. 31, 2020   24,456,914    
Beginning Balance at Dec. 31, 2019 4,380,545 $ 2,443 90,108,492 (85,730,390)
Beginning Balance, Shares at Dec. 31, 2019   24,431,914    
Net loss (10,886,809)      
Ending Balance at Sep. 30, 2020 (1,923,415) $ 2,633 94,691,151 (96,617,199)
Ending Balance, Shares at Sep. 30, 2020   26,332,122    
Beginning Balance at Mar. 31, 2020 2,921,648 $ 2,446 90,439,901 (87,520,699)
Beginning Balance, Shares at Mar. 31, 2020   24,456,914    
Stock-based compensation expense 362,955   362,955  
Issuance of common stock, net 3,309,116 $ 140 3,308,976  
Issuance of common stock, shares net   1,395,855    
Issuance of common stock from warrant exercises   $ 15 (15)  
Issuance of common stock from warrant exercise, shares   158,494    
Net loss (6,967,395)     (6,967,395)
Ending Balance at Jun. 30, 2020 (373,676) $ 2,601 94,111,817 (94,488,094)
Ending Balance, Shares at Jun. 30, 2020   26,011,263    
Stock-based compensation expense 478,574   478,574  
Issuance of common stock from stock option exercises 2,627 $ 1 2,626  
Issuance of common stock from stock option exercise, shares   4,237    
Issuance of common stock from employee stock purchase plan 98,165 $ 9 98,156  
Issuance of common stock from employee stock purchase plan, shares   93,491    
Issuance of common stock from warrant exercises   $ 22 (22)  
Issuance of common stock from warrant exercise, shares   223,131    
Net loss (2,129,105)     (2,129,105)
Ending Balance at Sep. 30, 2020 (1,923,415) $ 2,633 94,691,151 (96,617,199)
Ending Balance, Shares at Sep. 30, 2020   26,332,122    
Beginning Balance at Dec. 31, 2020 $ (3,214,623) $ 2,662 95,667,776 (98,885,061)
Beginning Balance, Shares at Dec. 31, 2020 26,621,954 26,621,954    
Stock-based compensation expense $ 561,348   561,348  
Issuance of common stock, net 13,070,154 $ 575 13,069,579  
Issuance of common stock, shares net   5,750,000    
Net loss (2,605,495)     (2,605,495)
Ending Balance at Mar. 31, 2021 7,811,384 $ 3,237 109,298,703 (101,490,556)
Ending Balance, Shares at Mar. 31, 2021   32,371,954    
Beginning Balance at Dec. 31, 2020 $ (3,214,623) $ 2,662 95,667,776 (98,885,061)
Beginning Balance, Shares at Dec. 31, 2020 26,621,954 26,621,954    
Net loss $ (6,865,590)      
Ending Balance at Sep. 30, 2021 $ 4,773,256 $ 3,266 110,520,641 (105,750,651)
Ending Balance, Shares at Sep. 30, 2021 32,656,480 32,656,480    
Beginning Balance at Mar. 31, 2021 $ 7,811,384 $ 3,237 109,298,703 (101,490,556)
Beginning Balance, Shares at Mar. 31, 2021   32,371,954    
Stock-based compensation expense 399,411   399,411  
Issuance of common stock from stock option exercises 45,454 $ 7 45,447  
Issuance of common stock from stock option exercise, shares   67,426    
Net loss (2,290,643)     (2,290,643)
Ending Balance at Jun. 30, 2021 5,965,606 $ 3,244 109,743,561 (103,781,199)
Ending Balance, Shares at Jun. 30, 2021   32,439,380    
Stock-based compensation expense 463,995   463,995  
Issuance of common stock, net 313,107 $ 22 313,085  
Issuance of common stock, shares net   217,100    
Net loss (1,969,452)     (1,969,452)
Ending Balance at Sep. 30, 2021 $ 4,773,256 $ 3,266 $ 110,520,641 $ (105,750,651)
Ending Balance, Shares at Sep. 30, 2021 32,656,480 32,656,480